Evidence map›Paper›PMID 33506953›Full record

Observational studyJournal of medical virology2021

Clinical characteristics and outcomes of COVID-19 in people living with HIV in Belgium: A multicenter, retrospective cohort.

Rakan Nasreddine, Eric Florence, Michel Moutschen, Jean-Cyr Yombi, Jean-Christophe Goffard, Inge Derdelinckx, Patrick Lacor, Linos Vandekerckhove, Peter Messiaen, Stefaan Vandecasteele and 3 more

Open access · bronzeAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Journal of medical virology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. HIV and COVID-19: review of clinical course and outcomes.HIV research & clinical practice · 2021
    Article
  5. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 9 institutions in 1 country.

Rakan NasreddineDivision of Infectious Diseases, Saint-Pierre University Hospital, Université Libre de Bruxelles, Brussels, Belgium.ORCID 0000-0002-1265-1500
Eric FlorenceDepartment of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Michel MoutschenDepartment of Infectious Diseases, Liège University Hospital, Université de Liège, Liège, Belgium.
Jean-Cyr YombiDepartment of Internal Medicine and Infectious Diseases, Saint-Luc University Hospital, Université Catholique de Louvain, Brussels, Belgium.
Jean-Christophe GoffardDepartment of Internal Medicine, Erasme University Hospital, Université Libre de Bruxelles, Brussels, Belgium.
Inge DerdelinckxDepartment of Internal Medicine, Leuven University Hospital, Katholieke Universiteit Leuven, Leuven, Belgium.
Patrick LacorDepartment of Internal Medicine and Infectious Diseases, Brussels University Hospital, Vrije Universiteit Brussel, Brussels, Belgium.
Linos VandekerckhoveDepartment of Internal Medicine and Pediatrics, Ghent University Hospital, Ghent University, Ghent, Belgium.
Peter MessiaenDepartment of Infectious Diseases and Immunity, Jessa Hospital, Hasselt, Belgium.
Stefaan VandecasteeleDepartment of Nephrology and Infectious Diseases, General Hospital Sint-Jan Brugge-Oostende AV, Bruges, Belgium.
Marc DelforgeDivision of Infectious Diseases, Saint-Pierre University Hospital, Université Libre de Bruxelles, Brussels, Belgium.
Stéphane De WitDivision of Infectious Diseases, Saint-Pierre University Hospital, Université Libre de Bruxelles, Brussels, Belgium.
Belgian Research on AIDS and HIV Consortium (BREACH)
Université Libre de Bruxelles · BEAZ Sint-Jan · BEGhent University Hospital · BEInstituut voor Tropische Geneeskunde · BEJessa Hospital · BEKU Leuven · BEUCLouvain · BEUniversity of Liège · BEVrije Universiteit Brussel · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to describe the clinical characteristics and outcomes of coronavirus disease 2019 (COVID-19) among people living with HIV (PLWH) in Belgium. We performed a retrospective multicenter cohort analysis of PLWH with either laboratory-confirmed, radiologically diagnosed, or clinically suspected COVID-19 between February 15, 2020 and May 31, 2020. The primary endpoint was outcome of COVID-19. Secondary endpoints included rate of hospitalization and length of hospital stay and rate of Intensive Care Unit (ICU) admission and mechanical ventilation. One hundred and one patients were included in this study. Patients were categorized as having either laboratory-confirmed (n = 65), radiologically-diagnosed (n = 3), or clinically suspected COVID-19 (n = 33). The median age was 51.3 years (interquartile range [IQR] 41.3-57.3) and 44% were female. Ninety-four percent of patients were virologically suppressed and 67% had a CD4

Indexed as

AdultBelgiumCase-Control StudiesCD4 Lymphocyte CountCOVID-19FemaleHIV InfectionsHospitalizationHumansMaleMiddle AgedRetrospective StudiesRisk FactorsSARS-CoV-2Treatment OutcomeBelgiumclinical characteristicsCOVID-19outcomespeople living with HIV

Identifiers

PMID33506953
PMCPMC8014531
OpenAlexW3124744076

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.